Delivery Order W81K0224D0009-W81K0225FA104
Award Date 9/29/25
Potential Completion Date 9/28/26
Potential Value $43K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South Korea
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price delivery order for $40,945.50 was awarded by the Defense Health Agency to Revvity Omics Inc., doing business as Perkinelmer Genetics, to provide newborn screening testing services for the Brian D. Allgood Army Community Hospital in South Korea. The order is for the base period of September 29, 2024 through September 28, 2025. Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc., is a for-profit organization that specializes in medical imaging and genetic...
- Revvity Omics Inc., operating as Perkinelmer Genetics, was awarded a $848,688 firm fixed-price purchase order by the Defense Health Agency on October 1, 2024, for newborn genetic testing services. The contract extends through September 30, 2029, and fulfills a Department of the Army Medical Command solicitation for comprehensive newborn screening services at William Beaumont Army Medical Center at Fort Bliss, Texas. The awarded contractor will conduct a panel of 13 genetic tests targeting...
- The Department of the Army Medical Command awarded a $37,989.49 firm fixed price delivery order to Perkinelmer Genetics, Inc. for newborn screening testing services at Brian D. Allgood Army Community Hospital/121st Combat Support Hospital in Korea. As the prime contractor, Perkinelmer Genetics will provide these services from September 2020 through September 2021 in support of the hospital's newborn screening program. Perkinelmer Genetics is a subsidiary of Revvity Inc., which focuses on medical...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Revvity Omics Inc., doing business as Perkinelmer Genetics, for newborn metabolic screening services. The contract, valued at $56,927.50, has an ultimate completion date of February 28, 2027. The contract was awarded without a small business set-aside designation. Perkinelmer Genetics, a subsidiary of Revvity Inc., specializes in providing comprehensive newborn screening testing services to federal government...
- The Department of the Army Medical Command awarded a $34,329.12 firm fixed price delivery order to Perkinelmer Genetics, Inc. for newborn screening testing services in support of the Brian D. Allgood Army Community Hospital and 121st Combat Support Hospital in Korea. The testing will be conducted under an Other Transaction for Prototype III agreement and is to be completed by September 28, 2023. Perkinelmer Genetics, Inc. is a subsidiary of Revvity Inc., which operates in the medical imaging...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Revvity Omics Inc., doing business as Perkinelmer Genetics, to provide newborn genetic screening services in accordance with the contract's Performance Work Statement. The $197,264 contract has an ultimate completion date of August 9, 2028. Perkinelmer Genetics is a subsidiary of the parent company Revvity Inc., which provides medical imaging products and services to federal agencies. This contract does not...
- This firm fixed-price purchase order contract was awarded by the Department of the Army Medical Command to Revvity Omics Inc., doing business as Perkinelmer Genetics, for comprehensive newborn screening services. The contract has a potential value of $375,186.00 and a completion date of September 30, 2016. Perkinelmer Genetics, a for-profit subsidiary of Revvity Inc., specializes in medical imaging and genetic testing services. This contract supports the military healthcare system by providing...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Revvity Omics Inc., doing business as Perkinelmer Genetics, for newborn screening services at the Weed Army Community Hospital in Fort Irwin, California. The contract has a total potential value of $165,711.65 over a five-year period from October 1, 2021 to September 30, 2026. The services include first and second newborn screening tests. This award is not associated with a larger contract vehicle, and the...
- This delivery order against the Defense Health Agency's Newborn Screening Testing Services contract awards Perkinelmer Genetics, Inc. $8,918.84 to provide newborn screening testing services for the Brian D. Allgood Army Community Hospital in South Korea from June 1, 2023 through September 28, 2023. As the prime contractor, Perkinelmer Genetics will perform the testing at its own facilities, with oversight from the Defense Health Agency. The contract has no set-aside designation and utilizes a...
- The Department of the Army Medical Command awarded a $45,092.88 firm fixed price delivery order to Perkinelmer Genetics, Inc. of Pittsburgh, Pennsylvania for newborn screening testing services in support of Brian D. Allgood Army Community Hospital and the 121st Combat Support Hospital in Korea. As the prime contractor, Perkinelmer Genetics will provide newborn screening to be performed at its laboratory in Pittsburgh on samples collected at the Army medical treatment facilities. The testing...